<< Back To Home

Phase 2b Controlled Trial of M72/ASO1E Vaccine to Prevent Tuberculosis

Friday, 1st of November 2019 Print

Phase 2b Controlled Trial of M72/ASO1E Vaccine to Prevent Tuberculosis

O van der Meeren et al., NEJM, 25 October 2019

https://www.nejm.org/doi/full/10.1056/NEJMoa1803484

24760492